8.57
price down icon7.25%   -0.67
after-market Dopo l'orario di chiusura: 8.57
loading
Precedente Chiudi:
$9.24
Aprire:
$9.26
Volume 24 ore:
2.11M
Relative Volume:
0.90
Capitalizzazione di mercato:
$527.44M
Reddito:
$3.64M
Utile/perdita netta:
$-87.37M
Rapporto P/E:
-2.0852
EPS:
-4.11
Flusso di cassa netto:
$-86.46M
1 W Prestazione:
-1.49%
1M Prestazione:
-13.26%
6M Prestazione:
+89.60%
1 anno Prestazione:
+187.58%
Intervallo 1D:
Value
$8.55
$9.30
Intervallo di 1 settimana:
Value
$8.49
$9.46
Portata 52W:
Value
$2.54
$11.24

Verastem Inc Stock (VSTM) Company Profile

Name
Nome
Verastem Inc
Name
Telefono
(781) 292-4200
Name
Indirizzo
117 KENDRICK STREET, NEEDHAM, MA
Name
Dipendente
78
Name
Cinguettio
@VerastemOncolog
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
VSTM's Discussions on Twitter

Confronta VSTM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VSTM
Verastem Inc
8.57 568.68M 3.64M -87.37M -86.46M -4.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Verastem Inc Stock (VSTM) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-10 Iniziato Jefferies Buy
2025-03-24 Reiterato H.C. Wainwright Buy
2024-12-31 Reiterato BTIG Research Buy
2024-09-30 Iniziato Guggenheim Buy
2023-11-21 Ripresa BTIG Research Buy
2023-09-27 Iniziato B. Riley Securities Buy
2023-06-15 Aggiornamento Mizuho Neutral → Buy
2022-09-07 Ripresa Alliance Global Partners Buy
2022-04-29 Ripresa Cantor Fitzgerald Overweight
2022-04-14 Iniziato RBC Capital Mkts Outperform
2022-03-09 Iniziato Truist Buy
2021-07-01 Iniziato Alliance Global Partners Buy
2021-05-24 Aggiornamento BTIG Research Neutral → Buy
2019-06-20 Downgrade BTIG Research Buy → Neutral
2019-05-10 Downgrade Raymond James Outperform → Mkt Perform
2018-07-13 Iniziato BTIG Research Buy
2018-05-02 Iniziato Seaport Global Securities Buy
2018-03-08 Iniziato B. Riley FBR, Inc. Buy
2017-09-07 Reiterato H.C. Wainwright Buy
2017-04-13 Iniziato Oppenheimer Outperform
2017-03-24 Reiterato H.C. Wainwright Buy
2015-09-29 Downgrade Cantor Fitzgerald Buy → Hold
2015-09-29 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2015-09-29 Downgrade Jefferies Buy → Hold
2015-09-29 Downgrade Raymond James Strong Buy → Outperform
2015-09-28 Downgrade Mizuho Buy → Neutral
2015-09-28 Downgrade ROTH Capital Buy → Neutral
2015-09-09 Iniziato Raymond James Strong Buy
2015-05-12 Reiterato UBS Buy
2015-04-08 Iniziato H.C. Wainwright Buy
2015-01-23 Reiterato ROTH Capital Buy
2014-07-08 Ripresa Oppenheimer Perform
2014-02-11 Iniziato Mizuho Buy
Mostra tutto

Verastem Inc Borsa (VSTM) Ultime notizie

pulisher
Oct 12, 2025

How to read the order book for Verastem Inc.July 2025 Reactions & High Yield Stock Recommendations - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Volume spikes in Verastem Inc. stock – what they mean2025 Buyback Activity & Expert Verified Stock Movement Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Verastem's (VSTM) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

What analysts say about Verastem Inc stockCandlestick Trading Patterns & High Return Stock Picks - earlytimes.in

Oct 09, 2025
pulisher
Oct 09, 2025

Using portfolio simulators with Verastem Inc. included2025 Major Catalysts & Fast Entry and Exit Trade Plans - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Verastem: Navigating Critical Steps In Commercialization And Development(Downgrade) (VSTM) - Seeking Alpha

Oct 07, 2025
pulisher
Oct 07, 2025

Verastem (NASDAQ:VSTM) Shares Up 4.9%Still a Buy? - MarketBeat

Oct 07, 2025
pulisher
Oct 07, 2025

Verastem Oncology announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener

Oct 07, 2025
pulisher
Oct 07, 2025

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Oct 07, 2025
pulisher
Oct 06, 2025

Analyzing net buyer seller activity in Verastem Inc.July 2025 Technicals & Daily Entry Point Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

When is the best time to exit Verastem Inc.Quarterly Earnings Report & Technical Pattern Recognition Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Verastem, Inc. (NASDAQ:VSTM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Verastem, Inc. (NASDAQ:VSTM) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Oct 06, 2025
pulisher
Oct 05, 2025

What sentiment indicators say about Verastem Inc. stockMarket Growth Summary & Real-Time Sentiment Analysis - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Verastem Inc. (2VSA) stock a buy before earnings resultsJuly 2025 Reactions & Consistent Return Strategy Ideas - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Historical volatility pattern of Verastem Inc. visualizedQuarterly Investment Review & Reliable Breakout Forecasts - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Verastem (NASDAQ:VSTM) Stock Passes Above 200-Day Moving AverageShould You Sell? - MarketBeat

Oct 04, 2025
pulisher
Oct 02, 2025

What analysts say about Verastem Inc 2VSA stockHigh Yield Income Stocks & Explosive Capital Growth - earlytimes.in

Oct 02, 2025
pulisher
Oct 01, 2025

Verastem Oncology to Report Q1 Earnings: What's in the Cards? - MSN

Oct 01, 2025
pulisher
Sep 26, 2025

Is Verastem Inc a good long term investmentStock Split Announcements & Build Your Portfolio With Our Free Stock Scanner - Early Times

Sep 26, 2025
pulisher
Sep 25, 2025

Insiders At Verastem Sold US$783k In Stock, Alluding To Potential Weakness - simplywall.st

Sep 25, 2025
pulisher
Sep 23, 2025

Verastem (NASDAQ:VSTM) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Goldman Sachs Group Inc. Has $4.56 Million Stake in Verastem, Inc. $VSTM - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Verastem (NASDAQ:VSTM) Shares Up 5.6%Here's Why - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Risk Recap: How is Verastem Inc managing supply chain issuesJuly 2025 Market Mood & Weekly Chart Analysis and Trade Guides - خودرو بانک

Sep 22, 2025
pulisher
Sep 21, 2025

Wall Street Zen Upgrades Verastem (NASDAQ:VSTM) to “Hold” - Defense World

Sep 21, 2025
pulisher
Sep 20, 2025

Momentum Shift: Is Verastem Inc forming a double bottomInflation Watch & Real-Time Market Sentiment Alerts - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Weekly Trades: Is WALD benefiting from interest rate changes2025 Support & Resistance & Safe Capital Investment Plans - khodrobank.com

Sep 20, 2025
pulisher
Sep 19, 2025

Can Verastem Inc. hit a new high this monthPortfolio Risk Summary & Real-Time Market Sentiment Reports - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Verastem Inc. stock trendline breakdownProduct Launch & Weekly High Conviction Ideas - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Verastem (VSTM) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Sep 19, 2025
pulisher
Sep 19, 2025

Gains Report: Is Verastem Inc. stock risky to hold nowMarket Weekly Review & Smart Swing Trading Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Verastem (NASDAQ:VSTM) Lowered to Sell Rating by Wall Street Zen - MarketBeat

Sep 18, 2025
pulisher
Sep 18, 2025

Insider Selling: Brian Stuglik Sells Shares of Verastem Inc (VST - GuruFocus

Sep 18, 2025
pulisher
Sep 18, 2025

Using economic indicators to assess Verastem Inc. potential2025 Year in Review & High Accuracy Trade Alerts - newser.com

Sep 18, 2025
pulisher
Sep 17, 2025

What indicators show strength in Verastem Inc.Weekly Market Report & High Yield Stock Recommendations - newser.com

Sep 17, 2025

Verastem Inc Azioni (VSTM) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Verastem Inc Azioni (VSTM) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Calkins Daniel
Chief Financial Officer
Sep 22 '25
Sale
9.08
57
518
109,863
Calkins Daniel
Chief Financial Officer
Sep 24 '25
Sale
9.23
25
231
109,838
Stuglik Brian M
Director
Sep 16 '25
Sale
9.99
587
5,864
101,739
Gagnon Robert E.
Director
Sep 16 '25
Sale
9.99
281
2,807
41,961
Paterson Dan
President and CEO
Sep 16 '25
Sale
9.99
390
3,896
442,117
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Capitalizzazione:     |  Volume (24 ore):